You are here: Industry Insights > COVID-19

News List

Two anti-inflammatory drugs may inhibit COVID-19 virus reproduction expresspharma
May 29, 2020
The findings show that at a concentration of 50 micromolar (μM) of Celecoxib or Carprofen, the inhibition of the in vitro activity of M-pro enzyme is 11.90 and 4.0 per cent, respectively.
Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery worldpharmanews
May 28, 2020
The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in The New England Journal of Medicine.
Appili set to evaluate favipiravir as preventive measure against Covid-19 pharmaceutical-business-review
May 28, 2020
Appili Therapeutics has secured regulatory clearance from Health Canada to move ahead with a phase 2 study for studying FUJIFILM Toyama Chemical’s favipiravir as a preventative measure against the outbreak of novel coronavirus (Covid-19).
Montefiore-Einstein Scientists Lead Two Trials of Leronlimab americanpharmaceuticalreview
May 28, 2020
Montefiore Health System and Albert Einstein College of Medicine are the evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19, and the other to treat severely ill COVID-19 patients.
Abbott Releases Interim Study Data on ID NOW COVID-19 Rapid Test americanpharmaceuticalreview
May 28, 2020
Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care clinics that indicates its ID NOW COVID-19 rapid test is showing strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments.
UK grants early access to Gilead’s remdesivir for Covid-19 pharmaceutical-technology
May 28, 2020
The UK Government has announced that some adults and adolescents hospitalised with Covid-19 on the National Health Service (NHS) will have access to Gilead Sciences’ remdesivir.
AbCellera raises $105m for antibody drug discovery platform pharmaceutical-technology
May 28, 2020
Canadian biotech firm AbCellera Biologics has raised $105m in a Series B funding round to advance its artificial intelligence (AI)-powered antibody drug discovery platform.
Novavax Expands Large-Scale Global Manufacturing Capacity contractpharma
May 28, 2020
Acquires Praha Vaccines in Czech Republic; annual operating capacity of over 1 billion doses of COVID-19 vaccine antigen.
Merck and Ridgeback Bio Collaborate contractpharma
May 28, 2020
Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, have entered into a collaboration agreement to develop EIDD-2801.
Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patient expresspharma
May 28, 2020
Biocon announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page